Effect of Reliable Recovery on Health Care Costs and Productivity Losses in Emotional Disorders.


Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
May 2024
Historique:
received: 20 12 2022
revised: 18 08 2023
accepted: 31 08 2023
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 26 4 2024
Statut: ppublish

Résumé

Despite the high economic costs associated with emotional disorders, relatively few studies have examined the variation in costs according to whether the patient has achieved a reliable recovery. The aim of this study was to explore differences in health care costs and productivity losses between primary care patients from a previous randomized controlled trial (RCT)-PsicAP-with emotional symptoms who achieved a reliable recovery and those who did not after transdiagnostic cognitive-behavioral therapy (TD-CBT) plus treatment as usual (TAU) or TAU alone. Sociodemographic and cost data were obtained for 134 participants treated at five primary care centers in Madrid for the 12-month posttreatment period. Reliable recovery rates were higher in the patients who received TD-CBT + TAU versus TAU alone (66% vs. 34%, respectively; chi-square = 13.78, df = 1, p < .001). Patients who did not achieve reliable recovery incurred more costs, especially associated with general practitioner consultations (t = 3.01, df = 132, p = .003), use of emergency departments (t = 2.20, df = 132, p = .030), total health care costs (t = 2.01, df = 132, p = .040), and sick leaves (t = 1.97, df = 132, p = .048). These findings underscore the societal importance of achieving a reliable recovery in patients with emotional disorders, and further support the value of adding TD-CBT to TAU in the primary care setting.

Identifiants

pubmed: 38670670
pii: S0005-7894(23)00104-1
doi: 10.1016/j.beth.2023.08.012
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-594

Informations de copyright

Copyright © 2023 Association for Behavioral and Cognitive Therapies. Published by Elsevier Ltd. All rights reserved.

Auteurs

Sara Barrio-Martínez (S)

Complutense University of Madrid and Valdecilla Biomedical Research Institute. Electronic address: sbarrio@idival.org.

Paloma Ruiz-Rodríguez (P)

Embarcaciones Primary Care Centre, Health Service of Madrid.

Leonardo Adrián Medrano (LA)

Pontificia Universidad Católica Madre y Maestra.

Amador Priede (A)

Valdecilla Biomedical Research Institute and Mental Health Centre, Hospital de Laredo.

Roger Muñoz-Navarro (R)

University of Valencia.

Juan Antonio Moriana (JA)

Universidad de Córdoba and Maimónides Institute for Research in Biomedicine of Cordoba.

María Carpallo-González (M)

University of Valencia.

Maider Prieto-Vila (M)

Complutense University of Madrid.

Antonio Cano-Vindel (A)

Complutense University of Madrid.

César González-Blanch (C)

Mental Health Centre, Marqués de Valdecilla University Hospital and Universidad Europea del Atlántico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH